Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Syagrus romanzoffiana pollen is a non-standardized allergenic extract derived from the pollen of the Queen palm tree (*Syagrus romanzoffiana*). It is used for diagnostic purposes in allergy testing to identify individuals with sensitivities to Queen palm pollen. Administration is via subcutaneous injection. A hypersensitivity reaction upon administration indicates an allergy, which can manifest as asthma, allergic rhinitis, and allergic conjunctivitis in susceptible individuals. The product is distributed by ALK-Abello, Inc.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Syagrus romanzoffiana pollen.